DE-114 ophthalmic solution

DRUG2 trials

Sponsors

Santen Pharmaceutical Co., Ltd.

Conditions

Allergic Conjunctivitis

Phase 3

A Long-term Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis

CompletedNCT01363713

Santen Pharmaceutical Co., Ltd.Allergic Conjunctivitis

Updated: 2014-10-06

Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis

CompletedNCT01363700

Santen Pharmaceutical Co., Ltd.Allergic Conjunctivitis

Updated: 2014-11-19

Related Papers

Efficacy of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival cedar pollen allergen challenge.

2014-08-2016 citations